Elevai Labs, Inc. Common Stock (ELAB) is a Healthcare · Biotechnology company listed on NASDAQ. Price $4.80 (+1.69%), Market cap $0.01B, 52-week low–high $0.71 ~ $14.00.
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and pro
Financial statements, price targets, institutional (13F) holdings and related news for Elevai Labs, Inc. Common Stock are updated in real time on BlackAll Trade.
Elevai Labs, Inc. Common Stock trades at $4.80 (+1.69%). Real-time quotes and charts are available on BlackAll Trade.
Elevai Labs, Inc. Common Stock has a market cap of about $0.01B.
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and